Korean-American biotech ‘Ingenia’ imminent listing on KOSDAQ

(Seoul = Yonhap News) Reporter Park Sang-hyun = Ingenia Therapeutics, a Korean bio company headquartered in the United States, is progressing smoothly to enter the KOSDAQ and listing is imminent...